McKesson + Celesio a Win-Win Deal

The drug wholesaler is up on reports that it will buy Celesio for $5 billion. However, McKesson looks cheap even without it.

Citing "people familiar with the matter," The Wall Street Journal reported Tuesday that drug wholesale giant McKesson (ticker: MCK) is in "advanced negotiations" with the majority shareholder of Celesio to buy the German rival for more than $5.08 billion.